Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.995 USD | -4.33% | -0.24% | -10.36% |
05-31 | Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-15 | Organovo's fatty liver disease drug meets main goal in mid-stage study | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.36% | 13.47M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- Organovo Holdings, Inc. Announces the Resignation of Eric David as Chief Strategy Officer and Executive Vice President of Preclinical Development, Effective December 12, 2017